Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
European Urology Oncology|August 19, 2020
Patterns of Cancer Progression of Metastatic Hormone-sensitive Prostate Cancer in the ECOG3805 CHAARTED TrialAlan H Bryce, Yu Hui Chen, Glenn Liu, et al.
Cancer Epidemiology|February 13, 2025
Treatment switching between Enzalutamide and Abiraterone Acetate and time to oral opioid initiation in castration-resistant prostate cancer patientsIbrahim M Asiri, Ronald C Chen, Viraj Master, et al.
Cancer|October 19, 2017
NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanomaRobert R McWilliams, Jacob B Allred, Jessica A Slostad, et al.
Prostate Cancer and Prostatic Diseases|July 23, 2021
Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancerMiguel Gonzalez Velez, Heidi E Kosiorek, Jan B Egan, et al.
Clinical Medicine Insights. Oncology|March 27, 2023
Clinical Outcomes of Stereotactic Radiosurgery-Related Radiation Necrosis in Patients with Intracranial Metastasis from MelanomaHolly M Thomson, Shannon P Fortin Ensign, Victoria S Edmonds, et al.
Prostate Cancer and Prostatic Diseases|November 7, 2023
Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant prostate cancerMohamed E Ahmed, Matthew S Lee, Ahmed M Mahmoud, et al.
Haematologica|February 13, 2009
Translocation t(11;14) and survival of patients with light chain (AL) amyloidosisAlan H Bryce, Rhett P Ketterling, Morie A Gertz, et al.
The Prostate|June 2, 2022
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastasesAlex J Liu, Heidi E Kosiorek, Benjamin E Ueberroth, et al.
Mayo Clinic Proceedings|April 12, 2021
Janus Kinase Inhibitors and Risk of Venous Thromboembolism: A Systematic Review and Meta-analysisJawad Bilal, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, et al.
JAMA Oncology|March 2, 2023
First-line Systemic Treatment Options for Metastatic Castration-Sensitive Prostate Cancer: A Living Systematic Review and Network Meta-analysisIrbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, Huan He, et al.
Pageof 10